TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
10-year audited capital structure, reserves & surplus, borrowings, solvency metrics, and working capital health.
Anuh Pharma Limited operates with a Debt-to-Equity ratio of 0.03x. The company carries negligible long-term borrowings, eliminating financial distress risks during macroeconomic rate hiking cycles.
With a Current Ratio of 2.03x and a ROCE of 15.9%, ANUHPHR possesses robust liquidity to fund organic capacity expansions and working capital requirements.
Yes, Anuh Pharma Limited (ANUHPHR) operates with a virtually debt-free balance sheet (Debt-to-Equity of 0.03x), providing strong solvency resilience and zero interest rate vulnerability.
Anuh Pharma Limited maintains a Current Ratio of 2.03x, indicating that its short-term current assets comfortably cover its immediate short-term obligations.
Anuh Pharma Limited maintains healthy retained earnings and equity reserves, supporting ongoing capital expenditures and reinvestment without substantial debt dilution.
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.